7Baggers
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.

Connect Biopharma Holdings Limited
(NASDAQ:CNTB) 

CNTB stock logo

Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, focuses on the discovery and development of immune modulators for the treatment of serious autoimmune diseases and inflammation. The company's lead product candidate is CBP-201, an anti-interleukin-4 receptor alpha antib...

Founded: 2012
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends
Connect Biopharma Days Payable Outstanding ttm (DPO)
202304 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 04.28.412.616.82125.229.4Thousand
Connect Biopharma Days Inventory Outstanding ttm (DIO)
202304 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 01,270.782,541.553,812.335,083.16,353.887,624.668,895.43
Connect Biopharma Op Cashflow Per Share ttm
202304 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -12.36-10.6-8.83-7.07-5.3-3.53-1.770
Connect Biopharma Free Cashflow Per Share ttm
202304 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -12.9-11.06-9.21-7.37-5.53-3.69-1.840
Connect Biopharma Cash Per Share ttm
202304 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 02.765.528.2811.0313.7916.5519.31
Connect Biopharma (GAAP) P/E ratio ttm
202304 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -5.36-4.59-3.83-3.06-2.3-1.53-0.770
Connect Biopharma P/B ratio ttm
202304 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -0.19-0.090.010.110.210.30.40.5
No extra charts and metrics for this ticker.